Title: Study of Hepatoprotective Effects of Xymedon.
Authors: Vyshtakalyuk, A.; Nazarov, N.; Zueva, I.; Lantsova, A.; Minnekhanova, O.; Busygin, D.; Porfiryev, A.; Evtyugin, V.; Reznik, V.; Zobov, V.
Abstract: Xymedon (1-(β-oxyethyl)-4,6-dimethyl-1,2-dihydro-2-oxopyrimidine), a regeneratory and wound-healing drug, exhibited hepatoprotective activity in laboratory animals with experimental toxic hepatitis. Oral drug reduced the severity of toxic involvement of the liver induced by CCl and reduced animal mortality. Xymedon promoted recovery of the blood biochemical parameters characterizing the liver status.
Subjects: HETEROCYCLIC compounds; ORGANIC cyclic compounds; WOUND healing; HEPATITIS treatment; LIVER disease treatment; PHYSIOLOGY
Publication: Bulletin of Experimental Biology & Medicine, 2013, Vol 155, Issue 5, p643
ISSN: 0007-4888
Publication type: Academic Journal
DOI: 10.1007/s10517-013-2215-0

Study of Hepatoprotective Effects of Xymedon.

Vyshtakalyuk, A.; Nazarov, N.; Zueva, I.; Lantsova, A.; Minnekhanova, O.; Busygin, D.; Porfiryev, A.; Evtyugin, V.; Reznik, V.; Zobov, V.